CHK1-IN-9
Product Specifications
Target
Chk
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CHK1-IN-9 (compound 11) is an orally active CHK1 inhibitor with an IC50 of 0.55 nM. It enhances the effects of DNA-damaging agents on tumor cells and exhibits synergistic anticancer activity with Gemcitabine.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2968-500 1x 500 µL
EGFR (Epidermal Growth Factor Receptor) (GFR/2968R), 0.2mg/mL
Sign In for Pricing
View Details 
BNC472149-100 1x 100 µL
Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC403625 20 µg
TORC2 (CRTC2) (NM_181715) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNUB1577-100 1x 100 µL
Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker) (KRTL/1577R), 0.2mg/mL
Sign In for Pricing
View Details 